Cannabidiol for Pain Relief in Advanced Prostate Cancer
Treatments studied
Part of Cancer, Kidney & urinary, Mental health clinical trials.
This trial tests whether cannabidiol (CBD), a non-intoxicating cannabis compound, can help relieve pain in patients with advanced prostate cancer that has stopped responding to standard treatments. You would take CBD daily alongside your current morphine pain medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Advanced prostate cancer (mCRPC) that has progressed despite standard treatments and you have no other approved options
- You have pain that requires at least 20mg of morphine daily (10mg taken twice a day)
- Your average pain level over the past week is at least 4 out of 10 on a pain scale
- You are generally able to care for yourself (ECOG performance status of 3 or better)
- Your liver and kidney function are adequate based on blood tests
- You have not used THC-containing cannabis products (regular marijuana) in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called INR731, given by mouth, for men with prostate cancer that has spread to other parts of the body. The study will check if the drug is safe and how well it works, either alone or combined with other prostate cancer medicines.
This Phase 3 trial tests a prostate cancer treatment plan chosen using your tumor’s biomarker results. It aims to improve outcomes for men with metastatic prostate cancer starting first systemic treatment.
This trial tests a new type of immune cell therapy (called AB-3028) designed to recognize and attack prostate cancer cells that have the PSMA protein on their surface. It's for people whose prostate cancer has spread and is no longer controlled by hormone therapy.
This study tests a cannabis-based extract to help control symptoms like pain, nausea, and anxiety in people with advanced cancer who are already on strong pain medication. It aims to improve your quality of life during treatment.
This early-phase study tests whether REGN4336 is safe and how well it works, by itself or with REGN5678, in adults with advanced prostate cancer. It may help people whose cancer has continued to worsen despite standard prostate cancer medicines.
This study tests a new drug called mevrometostat for men with a specific type of advanced prostate cancer that has spread and is still growing despite hormone therapy. It aims to see if the drug can help control the cancer.
Hear when a new Metastatic Castration Resistant Prostate Cancer (mCRPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.